In cryopyrin-associated periodic syndrome (CAPS), a group of rare diseases with an estimated prevalence of 1 in 360,000 persons [60], increased IL-1β activity plays a crucial role. This evidence concerns the gene IL1B and cryopyrin-associated periodic syndrome.